2021
DOI: 10.1080/07853890.2021.1891453
|View full text |Cite
|
Sign up to set email alerts
|

Performance of prediction models for short-term outcome in COVID-19 patients in the emergency department: a retrospective study

Abstract: Introduction Coronavirus disease 2019 (COVID-19) has a high burden on the healthcare system. Prediction models may assist in triaging patients. We aimed to assess the value of several prediction models in COVID-19 patients in the emergency department (ED). Methods In this retrospective study, ED patients with COVID-19 were included. Prediction models were selected based on their feasibility. Primary outcome was 30-day mortality, secondary outcomes were 14-day mortality … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
30
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 31 publications
(36 citation statements)
references
References 41 publications
2
30
0
Order By: Relevance
“…On the other hand, a recent study adopted a composite endpoint of mortality and admission to the medium/intensive care unit instead of IMV. 14 In this study, the 4C Mortality Score was not superior to the RISE UP score in predicting the composite endpoint. Although admission to the medium/intensive care unit generally reflects deterioration of general condition, including respiratory status, the difference in outcomes may explain the inconsistency of the results with ours.…”
Section: Discussionmentioning
confidence: 50%
See 2 more Smart Citations
“…On the other hand, a recent study adopted a composite endpoint of mortality and admission to the medium/intensive care unit instead of IMV. 14 In this study, the 4C Mortality Score was not superior to the RISE UP score in predicting the composite endpoint. Although admission to the medium/intensive care unit generally reflects deterioration of general condition, including respiratory status, the difference in outcomes may explain the inconsistency of the results with ours.…”
Section: Discussionmentioning
confidence: 50%
“…More recently, the performance of the 4C Mortality Score was tested in a single medical centre in the Netherlands; however, there was lack of generalisability and missing information on ethnicity. 14 At this point, it is noteworthy that the 4C Mortality Score performed well in the cohort of patients from the Japanese nationwide registry which has different features, including ethnicity, comorbidities and healthcare system. Despite these differences between the two cohorts, the 4C Mortality Score showed similar discriminatory ability to that in the previous study (AUC: 0.786).…”
Section: Discussionmentioning
confidence: 95%
See 1 more Smart Citation
“…A retrospective study of 403 adult patients seen in the Emergency Department in a combined secondary/tertiary care center in the Netherlands for the first wave of the pandemic (March through May, 2020) tested 11 prediction models of 30-day mortality as the primary outcome. [18]. The investigators identified two prediction models that performed best: 1) RISE-UP (acronym for Risk Stratification in the Emergency Department in Acutely Ill Older Patients) score, which included age, heart rate, mean arterial pressure, respiratory rate, oxygen saturation, Glasgow Coma Scale (GCS), BUN, bilirubin, albumin, and lactate dehydrogenase; and 2) 4-C (Coronavirus Clinical Characterization Consortium) score, which had been tested previously in the United Kingdom [19], and included age, sex, co-morbidity, RR, GCS, O 2 saturation, BUN, and CRP.…”
Section: Discussionmentioning
confidence: 99%
“…Sixty-one percent were older than 65 years; 48% were treated with oxygen � 4 Liters/minute within the first 24 hours of their hospital stay; radiographic pneumonia was present in 61%; ischemia in 37%; CRP > 10 mg/L was present in 47%; hospital length of stay was 12 ± 16 days; and in-hospital mortality was 36%. The mean number of co-morbid conditions was 2.5 ± 1.7; percentages (in parentheses) were as follows: hypertension (72), insulin-dependent diabetes (23), obesity (52), COPD (12), asthma (14), chronic liver disease (1), history of deep venous thrombosis (7), atrial fibrillation (13), coronary artery disease (23), chronic kidney disease (18), history of cerebrovascular disease (15), history of heart failure (23), history of malignancy (4). For some variables fewer than 100 data values were available; among these were (available numbers for analysis in parentheses): race/ ethnicity (81), SES (98), ischemia (99), pneumonia (98), CRP (95), BNP (42).…”
Section: Derivation Cohortmentioning
confidence: 99%